(Q46426588)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15816371%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

title

Spironolactone in the treatment of polycystic ovary syndrome: effects on clinical features, insulin sensitivity and lipid profile (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15816371%20AND%20SRC:MED&resulttype=core&format=json

polycystic ovary syndrome

10 January 2020

main subject

1 reference

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15816371%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

E Zulian

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15816371%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

P Sartorato

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15816371%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

S Benedini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15816371%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

G Baro

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15816371%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

D Armanini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15816371%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

F Mantero

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15816371%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

1 January 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15816371%20AND%20SRC:MED&resulttype=core&format=json

Journal of Endocrinological Investigation

10 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15816371%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15816371%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15816371%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

49-53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15816371%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf03345529

10 January 2020

exact match

0 references

cites work

Polycystic ovary syndrome: the new millenium

1 reference

https://api.crossref.org/works/10.1007%2FBF03345529

On the paradox of insulin-induced hyperandrogenism in insulin-resistant states

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345529

The insulin-like growth factor system in normal and abnormal human ovarian follicle development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345529

Cardiovascular risk in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345529

Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345529

Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345529

Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345529

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345529

Androgens and therapeutic aspects of antiandrogens in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345529

Comparison of four different treatment regimes in hirsutism related to polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345529

Hirsutism: metabolic effects of two commonly used oral contraceptives and spironolactone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345529

Insulin sensitivity in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345529

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345529

21 January 2018

Managing adolescent acne

1 reference

12 December 2020

The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women

1 reference

12 December 2020

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women

1 reference

12 December 2020

The Second International Symposium on the Developmental Aspects of Androgen Excess, Toronto, Canada, 20 June 2000

1 reference

12 December 2020

How actual is the treatment with antiandrogen alone in patients with polycystic ovary syndrome?

1 reference

12 December 2020

Treatment of hirsutism with spironolactone

1 reference

12 December 2020

Epidemiological approaches to heart disease: the Framingham Study

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03345529

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15816371%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference